NWM

Immunoassay, Anti-Seizure Drug

Product code

NWM

Device name

Immunoassay, Anti-Seizure Drug

Device class

Class 2

21 CFR

21 CFR 862.3350

Medical specialty

Clinical Toxicology

Marketing pathway

510(K)

Flag

Third-party review eligible

510(k) clearances (all years, FDA)

5 (all years; only the last 3 years are listed here)

FDA classification definition

To aid in management of patients treated with anti-seizure drug.

Definition text from the FDA device classification database (U.S. federal government work, public domain).